Central Garden & Pet Company CENT reported second-quarter fiscal 2025 results, wherein the top line missed the Zacks Consensus Estimate and declined year over year. Meanwhile, earnings surpassed the Zacks Consensus Estimate and improved from the same period last year. The company’s fiscal second-quarter results highlight solid execution and continued progress despite softer sales. Margin and earnings per share improved year over year, driven by strong productivity gains and disciplined implementation of the Cost and Simplicity program. While a significant portion of the garden season remains ahead and macroeconomic and geopolitical uncertainties persist, the company is reaffirming its full-year outlook and remains committed to executing its Central to Home strategy with operational excellence. In the second quarter of fiscal 2025, the company began winding down its operations in the U.K., and is transitioning to a direct-export model to serve customers in the U.K. and select European markets. This shift resulted in $5.3 million of initial non-cash charges to the Pet segment, including $4.4 million in cost of goods sold and $0.9 million in SG&A expenses. CENT’s Quarterly Performance: Key Metrics & Insights Central Garden & Pet posted quarterly adjusted earnings of $1.04 per share, which surpassed the Zacks Consensus Estimate of 94 cents. Also, the figure increased from 99 cents in the prior-year period. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.) Central Garden & Pet Company Price, Consensus and EPS SurpriseCentral Garden & Pet Company Price, Consensus and EPS Surprise Central Garden & Pet Company price-consensus-eps-surprise-chart | Central Garden & Pet Company Quote The company reported consolidated net sales of $833.5 million, which missed the Zacks Consensus Estimate of $875 million. The metric fell 7% from $900.1 million posted in the year-ago period. The adjusted gross profit was $277.5 million compared with $281.4 million reported in the year-ago period. The adjusted gross margin expanded 200 basis points (bps) to 33.3%, driven by productivity improvements from Central's Cost and Simplicity program. SG&A expenses of $179.8 million decreased 3% from $185.4 million year over year, indicating cost management across the organization. As a percentage of net sales, the figure increased 100 bps to 21.6%. We anticipated SG&A expenses, as a percentage of net sales, to increase 20 bps. The adjusted operating income was $98.7 million, in line with the figure reported in the year-ago period. The adjusted operating margin expanded 80 bps to 11.8%. Adjusted EBITDA was $123.3 million compared with $124.4 million in the prior-year period. Story Continues CENT’s Segment-Wise Performance Details Net sales for the Pet segment were $454 million, indicating a 6% decrease, which also missed our estimate of $468.5 million. This decline was largely due to the timing of customers' orders and promotional events in the first quarter, along with softer demand and assortment rationalization in durable pet products. The segment’s adjusted operating income was $65.9 million, up 5% from the prior-year quarter. The adjusted operating margin expanded 150 bps to 14.5%, supported by productivity improvements. In the Garden segment, net sales of $380 million declined 10% from the year-ago period and missed our estimate of $409.3 million. This decrease was due to pre-season order shifts into the first quarter, unfavorable weather that delayed the spring selling season and the discontinuation of two product lines in Central’s third-party distribution business. The adjusted segment’s operating income of $58.7 million decreased from $62.3 million reported in the prior-year quarter. The adjusted operating margin improved 70 bps to 15.5%, driven by productivity gains. CENT’s Financial Health Snapshot Central Garden & Pet ended the quarter with cash and cash equivalents of $516.7 million, long-term debt of $1,190.7 million and shareholders’ equity of $1,541.5 million, excluding the non-controlling interest of $1.9 million. The company repurchased about 1.2 million shares, or $41 million, in the quarter under review. Following the end of the quarter, Central repurchased an additional 1.2 million shares for $39 million through April 30, 2025. As of April 30, 2025, $63 million remained available for future stock repurchases. Management expects capital expenditures for fiscal 2025 to be $60 million. Sneak Peek Into CENT’s Outlook Central Garden & Pet reaffirms its guidance for 2025. The company continues to estimate fiscal 2025 adjusted earnings to be $2.20 per share or more, as mentioned earlier. This forecast takes into account factors such as the shifting consumer behavior amid ongoing macroeconomic and geopolitical uncertainty, challenges in the traditional retail market and unpredictability in weather patterns. The outlook excludes any potential effects from tariff rates, acquisitions, divestitures or restructuring activities, including initiatives related to the Cost and Simplicity program. Shares of this Zacks Rank #3 (Hold) company have lost 10.4% in the past three months compared with the industry’s decline of 8.2%. CENT Stock Price PerformanceZacks Investment Research Image Source: Zacks Investment Research Better-Ranked Stocks to Consider Sprouts Farmers SFM, which is engaged in the retailing of fresh, natural and organic food products, currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. SFM has a trailing four-quarter earnings surprise of 16.5%, on average. The Zacks Consensus Estimate for Sprouts Farmers’ current financial-year sales and earnings implies growth of around 13.7% and 32%, respectively, from the year-ago reported numbers. United Natural Foods, Inc. UNFI distributes natural, organic, specialty, produce and conventional grocery and non-food products in the United States and Canada. At present, United Natural carries a Zacks Rank of 2 (Buy). The consensus estimate for United Natural’s current fiscal-year sales and earnings implies growth of 1.9% and 485.7%, respectively, from the year-ago figures. UNFI delivered a trailing four-quarter earnings surprise of 408.7%, on average. BRF Brasil Foods SA BRFS, formerly Perdigao S.A., is a Brazil-based food company. It carries a Zacks Rank #2 at present. BRFS delivered a trailing four-quarter average earnings surprise of 9.6%. The consensus estimate for BRF’s current financial-year sales indicates growth of 0.3% from the prior-year reported levels. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Central Garden & Pet Company (CENT):Free Stock Analysis Report BRF S.A. (BRFS):Free Stock Analysis Report United Natural Foods, Inc. (UNFI):Free Stock Analysis Report Sprouts Farmers Market, Inc. (SFM):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research
Central Garden & Pet Q2 Earnings Surpass Estimates, Rise Y/Y
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...